| Product Code: ETC9678513 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Atherosclerosis Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Atherosclerosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Atherosclerosis Drugs Market - Industry Life Cycle |
3.4 Thailand Atherosclerosis Drugs Market - Porter's Five Forces |
3.5 Thailand Atherosclerosis Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Atherosclerosis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Atherosclerosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of atherosclerosis in Thailand |
4.2.2 Growing awareness about the importance of early detection and treatment of atherosclerosis |
4.2.3 Rise in healthcare expenditure and improving healthcare infrastructure in Thailand |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Thailand |
4.3.2 Presence of alternative treatment options for atherosclerosis |
4.3.3 High cost associated with atherosclerosis drugs |
5 Thailand Atherosclerosis Drugs Market Trends |
6 Thailand Atherosclerosis Drugs Market, By Types |
6.1 Thailand Atherosclerosis Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Anti-platelet Medications, 2021- 2031F |
6.1.4 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Cholesterol Lowering Medications, 2021- 2031F |
6.1.5 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Fibric Acid and Omega-3 Fatty Acid Derivatives, 2021- 2031F |
6.1.6 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.7 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Angiotensin-converting Enzyme (ACE) Inhibitors, 2021- 2031F |
6.1.8 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.1.9 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Atherosclerosis Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.3 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.4 Thailand Atherosclerosis Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Thailand Atherosclerosis Drugs Market Import-Export Trade Statistics |
7.1 Thailand Atherosclerosis Drugs Market Export to Major Countries |
7.2 Thailand Atherosclerosis Drugs Market Imports from Major Countries |
8 Thailand Atherosclerosis Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to atherosclerosis drug treatment |
8.2 Number of new drug approvals for atherosclerosis treatment in Thailand |
8.3 Percentage of population screened for atherosclerosis risk factors |
9 Thailand Atherosclerosis Drugs Market - Opportunity Assessment |
9.1 Thailand Atherosclerosis Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Atherosclerosis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Atherosclerosis Drugs Market - Competitive Landscape |
10.1 Thailand Atherosclerosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Atherosclerosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here